The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment.
about
Long term pharmacotherapy for obesity and overweight: updated meta-analysis.Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.The value of medical and pharmaceutical interventions for reducing obesity.Medications for obesity.
P2860
The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The clinical effectiveness and ...... sity: a technology assessment.
@ast
The clinical effectiveness and ...... sity: a technology assessment.
@en
The clinical effectiveness and ...... sity: a technology assessment.
@nl
type
label
The clinical effectiveness and ...... sity: a technology assessment.
@ast
The clinical effectiveness and ...... sity: a technology assessment.
@en
The clinical effectiveness and ...... sity: a technology assessment.
@nl
prefLabel
The clinical effectiveness and ...... sity: a technology assessment.
@ast
The clinical effectiveness and ...... sity: a technology assessment.
@en
The clinical effectiveness and ...... sity: a technology assessment.
@nl
P2093
P1476
The clinical effectiveness and ...... sity: a technology assessment.
@en
P2093
P577
2002-01-01T00:00:00Z